Sanike Swapna
A major challenge in utilizing Cannabis (Cannabis sativa L) for contemporary drugs is that the lack of standardization throughout the plant of cannabinoids, the distinctive therapeutic secondary metabolites in Cannabis. This study centered on the interaction between plant design modulation and standardization of the secondary substance profile in medical Cannabis plants. Secondary metabolism is significantly tormented by endogenous and exogenous factors, as well as positional-developmental aspects and microclimate. Medical-Cannabis genotypes of 'drugtype' medical Cannabis were analyzed to judge composition sensitivity. The results reveal that plant design modulation will increase standardization of the cannabinoid profile in Cannabis, thereby supporting the hypothesis.
